↓ Skip to main content

Monoamine oxidase B inhibitors for early Parkinson's disease

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monoamine oxidase B inhibitors for early Parkinson's disease
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd004898.pub2
Pubmed ID
Authors

Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell

Abstract

It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD). Clinical trials have produced conflicting results.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 1%
United States 1 1%
Colombia 1 1%
Unknown 70 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 22%
Student > Bachelor 11 15%
Researcher 10 14%
Student > Ph. D. Student 10 14%
Other 6 8%
Other 20 27%
Readers by discipline Count As %
Medicine and Dentistry 31 42%
Neuroscience 9 12%
Unspecified 8 11%
Agricultural and Biological Sciences 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 15 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2016.
All research outputs
#7,554,503
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#7,337
of 8,923 outputs
Outputs of similar age
#118,973
of 244,975 outputs
Outputs of similar age from Cochrane database of systematic reviews
#124
of 152 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.